Literature DB >> 16449287

Is it time for spironolactone therapy in dialysis patients?

Adrian Covic, Paul Gusbeth-Tatomir, David J A Goldsmith.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16449287     DOI： 10.1093/ndt/gfk086

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN： 0931-0509            Impact factor:   5.992


× No keyword cloud information.
  7 in total

Review 1.  Reducing cardiovascular mortality in chronic kidney disease: something borrowed, something new.

Authors:  L Darryl Quarles
Journal:  J Clin Invest       Date:  2013-01-09       Impact factor: 14.808

2.  A randomized, double-blind, placebo-controlled trial of spironolactone on carotid intima-media thickness in nondiabetic hemodialysis patients.

Authors:  Antonio Vukusich; Sonia Kunstmann; Cristian Varela; Daniela Gainza; Sebastian Bravo; Daniela Sepulveda; Gabriel Cavada; Luis Michea; Elisa T Marusic
Journal:  Clin J Am Soc Nephrol       Date:  2010-06-03       Impact factor: 8.237

3.  Long-term effects of spironolactone in peritoneal dialysis patients.

Authors:  Yasuhiko Ito; Masashi Mizuno; Yasuhiro Suzuki; Hirofumi Tamai; Takeyuki Hiramatsu; Hiroshige Ohashi; Isao Ito; Hirotake Kasuga; Masanobu Horie; Shoichi Maruyama; Yukio Yuzawa; Tatsuaki Matsubara; Seiichi Matsuo
Journal:  J Am Soc Nephrol       Date:  2013-12-12       Impact factor: 10.121

Review 4.  [Modern pharmacological aspects of hyperaldosteronism therapy].

Authors:  M Quinkler; M Reincke
Journal:  Internist (Berl)       Date:  2006-09       Impact factor: 0.743

Review 5.  [Conn's syndrome].

Authors:  E Born-Frontsberg; M Quinkler
Journal:  Internist (Berl)       Date:  2009-01       Impact factor: 0.743

6.  Disordered aldosterone-volume relationship in end-stage kidney disease.

Authors:  Andrew S Bomback; Abhijit V Kshirsagar; Maria E Ferris; Philip J Klemmer
Journal:  J Renin Angiotensin Aldosterone Syst       Date:  2009-10-28       Impact factor: 1.636

7.  Aldosterone and mortality in hemodialysis patients: role of volume overload.

Authors:  Szu-Chun Hung; Yao-Ping Lin; Hsin-Lei Huang; Hsiao-Fung Pu; Der-Cherng Tarng
Journal:  PLoS One       Date:  2013-02-28       Impact factor: 3.240
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.